A superficial colon tumor model involving subcutaneous colon translocation and orthotopic transplantation of green fluorescent protein-expressing human colon tumor

被引:15
作者
Jin, Heiying [1 ]
Yang, Zhijian [2 ]
Wang, Jiangdong [3 ]
Zhang, Suying [2 ]
Sun, Yu [2 ]
Ding, Yijiang [1 ]
机构
[1] Nanjing Univ Tradit Chinese Med, Natl Ctr Colorectal Surg, Affiliated Hosp 3, Nanjing 210001, Peoples R China
[2] Origin Biosci Inc, Nanjing 210009, Peoples R China
[3] Nanjing Gen Hosp PLA, Dept Pathol, Nanjing 210001, Peoples R China
关键词
Colorectal cancer; Orthotopic transplantation colon model; Fluorescent imaging; NUDE-MOUSE MODEL; CANCER; ANGIOGENESIS; METASTASIS; LIVER;
D O I
10.1007/s13277-010-0132-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The orthotopic transplantation model of human tumor has been demonstrated to be more patient-like animal tumor model. However, observations of tumor progression and metastasis are limited by the deep location of the colon or limited deep penetration ability of fluorescence through tissue. The purpose of this study is to establish a superficial orthotopic model to allow easier real-time visualization and more sensitive monitoring of fluorescent orthotopic colon tumor. Human colon cancer HT-29 cells were transduced with a pLPCX expression retroviral vector containing green fluorescent protein and neomycin resistance genes. For superficial orthotopic transplantation model, the cecum was identified and pulled out of the peritoneal cavity, the space between the cecum and peritoneum was sutured, the cecum was pulled to subcutaneous tissue, and incision was made on the cecal serosa followed by the implantation of a 1-mm tumor tissue to the cecum. For comparison, a conventional orthotopic transplantation model was established in a separate group of mice simultaneously. When tumor sizes reached 5 mm in diameter, half the mice in each model received 5-FU treatment. Primary tumor and metastases were monitored by fluorescent imaging or caliber measurement. Tumor fluorescence was observed as early as 3 days (median time of 4.7 +/- 1.3 days) post-transplantation in the superficial orthotopic transplantation model, which was much earlier than 21 days (median time of 26.2 +/- 9.9 days) in conventional orthotopic transplantation model. Although tumor growth of 5-FU-treated mice in conventional orthotopic model was lower than those of the untreated mice, the difference was not significant. However, in superficial orthotopic model, tumor growth was significantly inhibited in 5-FU-treated mice relative to the untreated mice. Fluorescence imaging showed similar metastasis incidence between the superficial and conventional orthotopic transplantation models. The fluorescent superficial orthotopic transplantation colon model allows easier real-time visualization and more sensitive monitoring of tumor growth as well as convenient repeated sampling. It is a valuable orthotopic implantation model for study of colon cancer and evaluation of new anti-cancer therapy.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 12 条
  • [1] Hoffman RA, 2005, METH MOLEC MED, V111, P297
  • [2] ORTHOTOPIC IS ORTHODOX - WHY ARE ORTHOTOPIC-TRANSPLANT METASTATIC MODELS DIFFERENT FROM ALL OTHER MODELS
    HOFFMAN, RM
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 56 (01) : 1 - 3
  • [3] Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis
    Hoffman, RM
    [J]. CANCER AND METASTASIS REVIEWS, 1998, 17 (03) : 271 - 277
  • [4] The multiple uses of fluorescent proteins to visualize cancer in vivo
    Hoffman, RM
    [J]. NATURE REVIEWS CANCER, 2005, 5 (10) : 796 - 806
  • [5] Whole-body imaging with fluorescent proteins
    Hoffman, Robert M.
    Yang, Meng
    [J]. NATURE PROTOCOLS, 2006, 1 (03) : 1429 - 1438
  • [6] Ji Y, 2007, ANTICANCER RES, V27, P713
  • [7] A simple colostomy implantation model for evaluating colon cancer
    Jin, Heiying
    Liu, Xiufang
    Li, Vicky ka ming
    Ding, Yijiang
    Yun, Shifeng
    Liu, Fei
    Zhou, Senmei
    Song, Yong
    Ni, Min
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (01) : 41 - 47
  • [8] Marchal F, 2005, ONCOL REP, V14, P1203
  • [9] Rashidi B, 2000, ANTICANCER RES, V20, P715
  • [10] Rho YS, 1999, ANTICANCER RES, V19, P157